CYTH - Cyclo Therapeutics GAAP EPS of -$0.33 beats by $0.14 revenue of $0.19M misses by $0.36M May, 12 2022 04:56 PM Cyclo Therapeutics Inc. Cyclo Therapeutics press release (NASDAQ:CYTH): Q1 GAAP EPS of -$0.33 beats by $0.14. Revenue of $0.19M (-47.2% Y/Y) misses by $0.36M. For further details see: Cyclo Therapeutics GAAP EPS of -$0.33 beats by $0.14, revenue of $0.19M misses by $0.36M